Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.4 USD | +2.65% |
|
+4.82% | 0.00% |
24/06 | ArriVent BioPharma, Inc.(NasdaqGM:AVBP) added to S&P Global BMI Index | CI |
05/06 | ArriVent, Alphamab Unit to Collaborate on Antibody Drug Conjugates For Cancer Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 58Cr | |
+21.85% | 4.64TCr | |
+38.68% | 3.91TCr | |
-8.05% | 3.88TCr | |
+29.04% | 3.12TCr | |
-13.75% | 2.58TCr | |
+10.65% | 2.59TCr | |
+38.43% | 1.31TCr | |
-6.92% | 1.13TCr | |
-12.29% | 1.07TCr |
- Stock Market
- Equities
- AVBP Stock
- News ArriVent BioPharma, Inc.
- Jefferies Starts ArriVent BioPharma With Buy Rating, $35 Price Target